Preserved MHC-II antigen processing and presentation function in chronic HCV infection

Cellular Immunology

Volumn 266, Issue 2, 2011, Pages 187-191

  Canaday, D H ^a,b   Burant, C J ^b,c   Jones, L ^a   Aung, H ^a   Woc Colburn, L ^d   Anthony, D D ^a,b  

^a GRECC   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antigen presentation; Dendritic cells; Hepatitis C; Immunology; MHC II; Monocytes

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYBRIDOMA; MALE; MONOCYTE; PRIORITY JOURNAL;

AGED; ANTIGEN PRESENTATION; DENDRITIC CELLS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYBRIDOMAS; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES;

HEPATITIS C VIRUS;

EID: 78649964701     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.10.003     Document Type: Article

References (33)

1. Freeman A.J., Dore G.J., Law M.G., Thorpe M., Von Overbeck J., Lloyd A.R., Marinos G., Kaldor J.M. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001, 34:809-816.
2. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
3. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5:558-567.
4. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 1998, 338:286-290.
5. Keeffe E.B. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am. J. Med. 2005, 118(Suppl. 10A):21S-27S.
6. Keeffe E.B., Iwarson S., McMahon B.J., Lindsay K.L., Koff R.S., Manns M., Baumgarten R., Wiese M., Fourneau M., Safary A., Clemens R., Krause D.S. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998, 27:881-886.
7. Lee S.D., Chan C.Y., Yu M.I., Wang Y.J., Chang F.Y., Lo K.J., Safary A. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J. Med. Virol. 1997, 52:215-218.
8. Wiedmann M., Liebert U.G., Oesen U., Porst H., Wiese M., Schroeder S., Halm U., Mossner J., Berr F. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000, 31:230-234.
9. Buxton J.A., Yu A., Kim P.H., Spinelli J.J., Kuo M., Alvarez M., Gilbert M., Krajden M. HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health 2010, 10:225.
10. Piccioli D., Tavarini S., Nuti S., Colombatto P., Brunetto M., Bonino F., Ciccorossi P., Zorat F., Pozzato G., Comar C., Abrignani S., Wack A. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J. Hepatol. 2005, 42:61-67.
11. Longman R.S., Talal A.H., Jacobson I.M., Rice C.M., Albert M.L. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J. Infect. Dis. 2005, 192:497-503.
12. Yonkers N.L., Rodriguez B., Milkovich K.A., Asaad R., Lederman M.M., Heeger P.S., Anthony D.D. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J. Immunol. 2007, 178:4436-4444.
13. Tsubouchi E., Akbar S.M., Horiike N., Onji M. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J. Gastroenterol. 2004, 39:754-762.
14. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., Oki C., Itose I., Hiramatsu N., Takehara T., Kasahara A., Hayashi N. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 2004, 190:1919-1926.
15. Tzachanis D., Berezovskaya A., Nadler L.M., Boussiotis V.A. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 2002, 99:1465-1473.
16. Tan P., Anasetti C., Hansen J.A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J.A., Linsley P.S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 1993, 177:165-173.
17. Woc-Colburn L., Smultea L., Ramachandra L., Canaday D.H. Preserved MHC Class II Antigen Processing in Monocytes from HIV-Infected Individuals. PLoS One 2010, 5:e9491.
18. Canaday D.H., Gehring A., Leonard E.G., Eilertson B., Schreiber J.R., Harding C.V., Boom W.H. T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing. J. Immunol. Methods 2003, 281:129-142.
19. Canaday D.H., Chakravarti S., Srivastava T., Tisch D.J., Cheruvu V.K., Smialek J., Harding C.V., Ramachandra L. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cell Immunol. 2006, 243:96-106.
20. Shaheen A.A., Myers R.P. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007, 46:912-921.
21. Sinn D.H., Paik S.W., Kang P., Kil J.S., Park S.U., Lee S.Y., Song S.M., Gwak G.Y., Choi M.S., Lee J.H., Koh K.C., Yoo B.C. Disease progression and the risk factor analysis for chronic hepatitis C. Liver Int. 2008, 28:1363-1369.
22. Ngo Y., Munteanu M., Messous D., Charlotte F., Imbert-Bismut F., Thabut D., Lebray P., Thibault V., Benhamou Y., Moussalli J., Ratziu V., Poynard T. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin. Chem. 2006, 52:1887-1896.
23. Nunes D., Fleming C., Offner G., Craven D., Fix O., Heeren T., Koziel M.J., Graham C., Tumilty S., Skolnik P., Stuver S., Horsburgh C.R., Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am. J. Gastroenterol. 2010, 105:1346-1353.
24. Jones L., McDonald D., Canaday D.H. Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells. AIDS Res. Hum. Retroviruses 2007, 23:812-816.
25. Auffermann-Gretzinger S., Keeffe E.B., Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001, 97:3171-3176.
26. Anthony D.D., Yonkers N.L., Post A.B., Asaad R., Heinzel F.P., Lederman M.M., Lehmann P.V., Valdez H. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 2004, 172:4907-4916.
27. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., Sasaki Y., Kasahara A., Hori M. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 1999, 162:5584-5591.
28. Rodrigue-Gervais I.G., Jouan L., Beaule G., Sauve D., Bruneau J., Willems B., Sekaly R.P., Lamarre D. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J. Virol. 2007, 81:5537-5546.
29. Rodrigue-Gervais I.G., Rigsby H., Jouan L., Sauve D., Sekaly R.P., Willems B., Lamarre D. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J. Immunol. 2010, 184:3134-3144.
30. Kanto T., Inoue M., Miyazaki M., Itose I., Miyatake H., Sakakibara M., Yakushijin T., Kaimori A., Oki C., Hiramatsu N., Kasahara A., Hayashi N. Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 2006, 49:58-63.
31. Wertheimer A.M., Bakke A., Rosen H.R. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 2004, 40:335-345.
32. Dolganiuc A., Paek E., Kodys K., Thomas J., Szabo G. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 2008, 135:2119-2127.
33. Nisii C., Tempestilli M., Agrati C., Poccia F., Tocci G., Longo M.A., D'Offizi G., Tersigni R., Lo Iacono O., Antonucci G., Oliva A. Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection. J. Hepatol. 2006, 44:475-483.